• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Management of Coronavirus Disease-2019 Infection in Pregnancy.妊娠期 2019 年冠状病毒病感染的管理。
Emerg Med Clin North Am. 2023 May;41(2):307-322. doi: 10.1016/j.emc.2022.12.004. Epub 2022 Dec 16.
2
Impact of COVID-19 on Pregnancy.COVID-19 对妊娠的影响。
Int J Med Sci. 2021 Jan 1;18(3):763-767. doi: 10.7150/ijms.49923. eCollection 2021.
3
COVID-19 in pregnancy and the puerperium: A review for emergency physicians.COVID-19 与妊娠及产褥期:急诊医师相关综述。
Am J Emerg Med. 2021 Feb;40:193-198. doi: 10.1016/j.ajem.2020.10.055. Epub 2020 Nov 2.
4
The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis.冠状病毒感染(SARS-CoV-2、MERS-CoV 和 SARS-CoV)对妊娠的影响及垂直母婴传播的可能性:系统评价和荟萃分析。
Eur J Med Res. 2020 Sep 4;25(1):39. doi: 10.1186/s40001-020-00439-w.
5
Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.患有严重或危急 2019 冠状病毒病的孕妇与未怀孕的匹配对照相比,复合发病率增加。
Am J Obstet Gynecol. 2021 May;224(5):510.e1-510.e12. doi: 10.1016/j.ajog.2020.11.022. Epub 2020 Nov 20.
6
Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection.患有和未患有严重急性呼吸综合征冠状病毒 2 感染的女性的妊娠结局。
JAMA Netw Open. 2020 Nov 2;3(11):e2029256. doi: 10.1001/jamanetworkopen.2020.29256.
7
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.新型冠状病毒病 2019(COVID-19)与妊娠:产科医生须知。
Am J Obstet Gynecol. 2020 May;222(5):415-426. doi: 10.1016/j.ajog.2020.02.017. Epub 2020 Feb 24.
8
A multidisciplinary telemedicine model for management of coronavirus disease 2019 (COVID-19) in obstetrical patients.多学科远程医疗模式在妇产科患者 2019 冠状病毒病(COVID-19)管理中的应用。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100180. doi: 10.1016/j.ajogmf.2020.100180. Epub 2020 Jul 25.
9
COVID-19 Pandemic and Pregnancy in Kidney Disease.COVID-19 大流行与肾脏病患者妊娠
Adv Chronic Kidney Dis. 2020 Sep;27(5):397-403. doi: 10.1053/j.ackd.2020.08.005. Epub 2020 Aug 7.
10
Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State.华盛顿州 46 例严重急性呼吸综合征冠状病毒 2 感染孕妇的临床特征。
Am J Obstet Gynecol. 2020 Dec;223(6):911.e1-911.e14. doi: 10.1016/j.ajog.2020.05.031. Epub 2020 May 19.

本文引用的文献

1
Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.新冠肺炎患者在疫情四波期间插管时机的影响:一项匹配分析。
Eur Respir J. 2023 Mar 2;61(3). doi: 10.1183/13993003.01426-2022. Print 2023 Mar.
2
Short-term Pregnancy Outcomes After Nirmatrelvir-Ritonavir Treatment for Mild-to-Moderate Coronavirus Disease 2019 (COVID-19).奈玛特韦/利托那韦治疗轻症至中症 2019 冠状病毒病(COVID-19)后的短期妊娠结局。
Obstet Gynecol. 2022 Sep 1;140(3):447-449. doi: 10.1097/AOG.0000000000004900. Epub 2022 Jun 28.
3
JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study.JAK 抑制剂与主要心血管事件或静脉血栓栓塞风险:一项自身对照病例系列研究。
Eur J Clin Pharmacol. 2022 Dec;78(12):1981-1990. doi: 10.1007/s00228-022-03402-2. Epub 2022 Oct 26.
4
Safety and efficacy of anti-SARS-CoV-2 monoclonal antibodies in pregnancy.抗SARS-CoV-2单克隆抗体在妊娠期的安全性和有效性。
Expert Opin Drug Saf. 2022 Sep;21(9):1137-1141. doi: 10.1080/14740338.2022.2122436. Epub 2022 Sep 15.
5
Examining the impact of trimester of diagnosis on COVID-19 disease progression in pregnancy.研究诊断孕周对妊娠期COVID-19疾病进展的影响。
Am J Obstet Gynecol MFM. 2022 Nov;4(6):100728. doi: 10.1016/j.ajogmf.2022.100728. Epub 2022 Aug 20.
6
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.替沙格韦单抗-西加韦单抗用于治疗住院 COVID-19 患者:一项随机、双盲、3 期临床试验。
Lancet Respir Med. 2022 Oct;10(10):972-984. doi: 10.1016/S2213-2600(22)00215-6. Epub 2022 Jul 8.
7
A dual-center cohort study on the association between early deep sedation and clinical outcomes in mechanically ventilated patients during the COVID-19 pandemic: The COVID-SED study.一项关于 COVID-19 大流行期间机械通气患者早期深度镇静与临床结局之间关联的中心队列研究:COVID-SED 研究。
Crit Care. 2022 Jun 15;26(1):179. doi: 10.1186/s13054-022-04042-9.
8
Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.替沙格韦单抗-西加韦单抗肌内注射用于 COVID-19 早期门诊治疗的疗效和安全性(TACKLE):一项 3 期、随机、双盲、安慰剂对照试验。
Lancet Respir Med. 2022 Oct;10(10):985-996. doi: 10.1016/S2213-2600(22)00180-1. Epub 2022 Jun 7.
9
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure: A Randomized Clinical Trial.清醒俯卧位对 COVID-19 合并急性呼吸衰竭患者经口气管插管的影响:一项随机临床试验。
JAMA. 2022 Jun 7;327(21):2104-2113. doi: 10.1001/jama.2022.7993.
10
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.奈玛特韦片/利托那韦片组合包装口服药用于伴有进展为重症高风险因素的 COVID-19 门诊患者。
N Engl J Med. 2022 Apr 14;386(15):1397-1408. doi: 10.1056/NEJMoa2118542. Epub 2022 Feb 16.

妊娠期 2019 年冠状病毒病感染的管理。

Management of Coronavirus Disease-2019 Infection in Pregnancy.

机构信息

Department of Internal Medicine, Section of Critical Care Medicine, Advocate Christ Medical Center, 4440 West 95th Street, Suite AIP, Oak Lawn, IL 60453, USA.

Department of Internal Medicine, Section of Critical Care Medicine, Advocate Christ Medical Center, 4440 West 95th Street, Suite AIP, Oak Lawn, IL 60453, USA; Division of Pulmonary & Critical Care, Department of Internal Medicine, University of Maryland, School of Medicine, 110 South Paca Street, 6th Floor Suite 200, Baltimore, MD 21201, USA.

出版信息

Emerg Med Clin North Am. 2023 May;41(2):307-322. doi: 10.1016/j.emc.2022.12.004. Epub 2022 Dec 16.

DOI:10.1016/j.emc.2022.12.004
PMID:37024166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9755010/
Abstract

Although the majority of pregnant patients who contract severe acute respiratory syndrome coronavirus 2 will have a mild course of illness, pregnant patients with coronavirus disease-2019 are more likely than their nonpregnant counterparts to develop a severe illness with an increased risk of poor maternal and fetal outcomes. Although the extent of research in this specific patient population remains limited, there are tenets of care with which physicians and other providers must be familiar to increase the chances of better outcomes for the two patients in their care.

摘要

虽然大多数感染严重急性呼吸综合征冠状病毒 2 的孕妇患者病情较轻,但感染 2019 年冠状病毒病的孕妇比非孕妇更容易出现严重疾病,母婴结局较差的风险增加。尽管针对这一特定患者群体的研究还很有限,但医生和其他提供者必须熟悉一些护理原则,以增加他们所照顾的两名患者获得更好结果的机会。